The pathophysiology of IgA nephropathy

Journal of the American Society of Nephrology

Volumn 22, Issue 10, 2011, Pages 1795-1803

  Suzuki, Hitoshi ^a,c   Kiryluk, Krzysztof ^b   Novak, Jan ^c   Moldoveanu, Zina ^c   Herr, Andrew B ^f   Renfrow, Matthew B ^d   Wyatt, Robert J ^g   Scolari, Francesco ^h   Mestecky, Jiri ^c,e   Gharavi, Ali G ^b   Julian, Bruce A ^c,e  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b College of Physicians and Surgeons ^*  (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e University of Alabama at Birmingham   (United States)

^f UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^g UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^h UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; IMMUNOGLOBULIN A1;

CHROMOSOME 22Q; CHROMOSOME 6P; CYTOKINE PRODUCTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GLOMERULONEPHRITIS; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOPATHOGENESIS; KIDNEY INJURY; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; REVIEW;

EID: 80053534268     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2011050464     Document Type: Review

References (56)

1. Berger J, Hinglais N: Les dépôts intercapillaires d'IgA-IgG (Intercapillary deposits of IgA-IgG). J Urol Nephrol 74: 694-695, 1968
2. Silva FG, Chander P, Pirani CL, Hardy MA: Disappearance of glomerular mesangial IgA deposits after renal allograft transplantation. Transplantation 33: 241-246, 1982
3. Gharavi AG, Kiryluk K, Choi M, Li Y, Hou P, Xie J, Sanna-Cherchi S, Men CJ, Julian BA, Wyatt RJ, Novak J, He JC, Wang H, Lv J, Zhu L, Wang W, Wang Z, Yasuno K, Gunel M, Mane S, Umlauf S, Tikhonova I, Beerman I, Savoldi S, Magistroni R, Ghiggeri GM, Bodria M, Lugani F, Ravani P, Ponticelli C, Allegri L, Boscutti G, Frasca G, Amore A, Peruzzi L, Coppo R, Izzi C, Viola BF, Prati E, Salvadori M, Mignani R, Gesualdo L, Bertinetto F, Mesiano P, Amoroso A, Scolari F, Chen N, Zhang H, Lifton RP: Genome-wide association study identifies susceptibility loci for IgA nephropathy. Nat Genet 43: 321-327, 2011
4. Coppo R, Feehally J, Glassock RJ: IgA nephropathy at two score and one. Kidney Int 77: 181-186, 2010
5. Mestecky J, Moro I, Kerr MA, Woof JM: Mucosal immunoglobulins. In: Mucosal Immunology, 3rd ed, edited by Mestecky J, Bienenstock J, Lamm ME, Mayer L, McGhee JR, Strober W, Amsterdam, Elsevier Academic Press, 2005, pp 153-181
6. Moldoveanu Z, Wyatt RJ, Lee J, Tomana M, Julian BA, Mestecky J, Huang WQ, Anreddy S, Hall S, Hastings MC, Lau KK, Cook WJ, Novak J: Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels. Kidney Int 71: 1148-1154, 2007 (Pubitemid 46809135)
7. Renfrow MB, Cooper HJ, Tomana M, Kulhavy R, Hiki Y, Toma K, Emmett MR, Mestecky J, Marshall AG, Novak J: Determination of aberrant O-glycosylation in the IgA1 hinge region by electron capture dissociation Fourier transform-ion cyclotron resonance mass spectrometry. J Biol Chem 280: 19136-19145, 2005 (Pubitemid 41379620)
8. Renfrow MB, MacKay CL, Chalmers MJ, Julian BA, Mestecky J, Kilian M, Poulsen K, Emmett MR, Marshall AG, Novak J: Analysis of O-glycan heterogeneity in IgA1 myeloma proteins by Fourier transform ion cyclotron resonance mass spectrometry: Implications for IgA nephropathy. Anal Bioanal Chem 389: 1397-1407, 2007 (Pubitemid 350023664)
9. Takahashi K, Wall SB, Suzuki H, Smith AD, Hall S, Poulsen K, Kilian M, Mobley JA, Julian BA, Mestecky J, Novak J, Renfrow MB: Clustered O-glycans of IgA1: Defining macro-and micro-heterogeneity by use of electron capture/transfer dissociation. Mol Cell Proteomics 9: 2545-2557, 2010
10. Wada Y, Dell A, Haslam SM, Tissot B, Canis K, Azadi P, Backstrom M, Costello CE, Hansson GC, Hiki Y, Ishihara M, Ito H, Kakehi K, Karlsson N, Hayes CE, Kato K, Kawasaki N, Khoo KH, Kobayashi K, Kolarich D, Kondo A, Lebrilla C, Nakano M, Narimatsu H, Novak J, Novotny MV, Ohno E, Packer NH, Palaima E, Renfrow MB, Tajiri M, Thomsson KA, Yagi H, Yu SY, Taniguchi N: Comparison of methods for profiling O-glycosylation: Human Proteome Organisation Human Disease Glycomics/ Proteome Initiative multi-institutional study of IgA1. Mol Cell Proteomics 9: 719-727, 2010
11. Wada Y, Tajiri M, Ohshima S: Quantitation of saccharide compositions of O-glycans by mass spectrometry of glycopeptides and its application to rheumatoid arthritis. J Proteome Res 9: 1367-1373, 2010
12. Odani H, Yamamoto K, Iwayama S, Iwase H, Takasaki A, Takahashi K, Fujita Y, Sugiyama S, Hiki Y: Evaluation of the specific structures of IgA1 hinge glycopeptide in 30 IgA nephropathy patients by mass spectrometry. J Nephrol 23: 70-76, 2010
13. Suzuki H, Fun R, Zhang Z, Brown R, Hall S, Julian BA, Chatham WW, Suzuki Y, Wyatt RJ, Moldoveanu Z, Lee JY, Robinson J, Tomana M, Tomino Y, Mestecky J, Novak J: Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. J Clin Invest 119: 1668-1677, 2009
14. Smith AC, Molyneux K, Feehally J, Barratt J: O-glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy. J Am Soc Nephrol 17: 3520-3528, 2006 (Pubitemid 44865295)
15. Suzuki H, Suzuki Y, Narita I, Aizawa M, Kihara M, Yamanaka T, Kanou T, Tsukaguchi H, Novak J, Horikoshi S, Tomino Y: Toll-like receptor 9 affects severity of IgA nephropathy. J Am Soc Nephrol 19: 2384-2395, 2008
16. Gharavi AG, Moldoveanu Z, Wyatt RJ, Barker CV, Woodford SY, Lifton RP, Mestecky J, Novak J, Julian BA: Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy. J Am Soc Nephrol 19: 1008-1014, 2008
17. Kiryluk K, Julian BA, Wyatt RJ, Scolari F, Zhang H, Novak J, Gharavi AG: Genetic studies of IgA nephropathy: Past, present, and future. Pediatr Nephrol 25: 2257-2268, 2010
18. Imielinski M, Baldassano RN, Griffiths A, Russell RK, Annese V, Dubinsky M, Kugathasan S, Bradfield JP, Walters TD, Sleiman P, Kim CE, Muise A, Wang K, Glessner JT, Saeed S, Zhang H, Frackelton EC, Hou C, Flory JH, Otieno G, Chiavacci RM, Grundmeier R, Castro M, Latiano A, Dallapiccola B, Stempak J, Abrams DJ, Taylor K, McGovern D, Silber G, Wrobel I, Quiros A, Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, Rioux JD, Brant SR, Silverberg MS, Taylor KD, Barmuda MM, Bitton A, Dassopoulos T, Datta LW, Green T, Griffiths AM, Kistner EO, Murtha MT, Regueiro MD, Rotter JI, Schumm LP, Steinhart AH, Targan SR, Xavier RJ, Libioulle C, Sandor C, Lathrop M, Belaiche J, Dewit O, Gut I, Heath S, Laukens D, Mni M, Rutgeerts P, van Gossum A, Zelenika D, Franchimont D, Hugot JP, De Vos M, Vermeire S, Louis E, Cardon LR, Anderson CA, Drummond H, Nimmo E, Ahmad T, Prescott NJ, Onnie CM, Fisher SA, Marchini J, Ghori J, Bumpstead S, Gwillam R, Tremelling M, Delukas P, Mansfield J, Jewell D, Satsangi J, Mathew CG, Parkes M, Georges M, Daly MJ, Heyman MB, Ferry GD, Kirschner B, Lee J, Essers J, Grand R, Stephens M, Levine A, Piccoli D, van Limbergen J, Cucchiara S, Monos DS, Guthery SL, Denson L, Wilson DC, Grant SF, Daly M, Hakonarson H: Common variants at five new loci associated with early-onset inflammatory bowel disease. Nat Genet 41: 1335-1340, 2009
19. Tomana M, Novak J, Julian BA, Matousovic K, Konecny K, Mestecky J: Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Invest 104: 73-81, 1999 (Pubitemid 29534347)
20. Bellur SS, Troyanov S, Cook HT, Roberts IS: Immunostaining findings in IgA nephropathy: Correlation with histology and clinical outcome in the Oxford classification patient cohort. Nephrol Dial Transplant 26: 2533-2536, 2011
21. Feehally J, Farrall M, Boland A, Gale DP, Gut I, Heath S, Kumar A, Peden JF, Maxwell PH, Morris DL, Padmanabhan S, Vyse TJ, Zawadzka A, Rees AJ, Lathrop M, Ratcliffe PJ: HLA has strongest association with IgA nephropathy in genome-wide analysis. J Am Soc Nephrol 21: 1791-1797, 2010
22. Solberg OD, Mack SJ, Lancaster AK, Single RM, Tsai Y, Sanchez-Mazas A, Thomson G: Balancing selection and heterogeneity across the classical human leukocyte antigen loci: A meta-analytic review of 497 population studies. Hum Immunol 69: 443-464, 2008
23. Glassock RJ: The pathogenesis of IgA nephropathy. Curr Opin Nephrol Hypertens 20: 153-160, 2011
24. Levinsky RJ, Barratt TM: IgA immune complexes in Henoch-Schönlein purpura. Lancet 2: 1100-1103, 1979 (Pubitemid 10211491)
25. Hall RP, Lawley TJ, Heck JA, Katz SI: IgAcontaining circulating immune complexes in dermatitis herpetiformis, Henoch-Schönlein purpura, systemic lupus erythematosus and other diseases. Clin Exp Immunol 40: 431-437, 1980 (Pubitemid 10070072)
26. Sterzel RB, Lovett DH, Stein HD, Kashgarian M: The mesangium and glomerulonephritis. Klin Wochenschr 60: 1077-1094, 1982 (Pubitemid 12015153)
27. Novak J, Tomana M, Matousovic K, Brown R, Hall S, Novak L, Julian BA, Wyatt RJ, Mestecky J: IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells. Kidney Int 67: 504-513, 2005 (Pubitemid 40139842)
28. Novak J, Moldoveanu Z, Renfrow MB, Yanagihara T, Suzuki H, Raska M, Hall S, Brown R, Huang WQ, Goepfert A, Kilian M, Poulsen K, Tomana M, Wyatt RJ, Julian BA, Mestecky J: IgA nephropathy and Henoch-Schoenlein purpura nephritis: Aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cells. Contrib Nephrol 157: 134-138, 2007
29. Novak J, Mestecky J: IgA Immune-complex. In: Recent Advances in IgA Nephropathy, edited by Lai KN, Hong Kong, Imperial College Press and the World Scientific Publisher, 2009, pp 177-191
30. Lai KN, Leung JC, Chan LY, Saleem MA, Mathieson PW, Lai FM, Tang SC: Activation of podocytes by mesangial-derived TNF-α: Glomerulo-podocytic communication in IgA nephropathy. Am J Physiol Renal Physiol 294: F945-F955, 2008
31. Lai KN, Leung JC, Chan LY, Saleem MA, Mathieson PW, Tam KY, Xiao J, Lai FM, Tang SC: Podocyte injury induced by mesangial-derived cytokines in IgA nephropathy. Nephrol Dial Transplant 24: 62-72, 2009
32. Leung JCK, Tsang AWL, Chan DTM, Lai KN: Absence of CD89, polymeric immunoglobulin receptor, and asialoglycoprotein receptor on human mesangial cells. J Am Soc Nephrol 11: 241-249, 2000 (Pubitemid 30064847)
33. Novak J, Vu HL, Novak L, Julian BA, Mestecky J, Tomana M: Interactions of human mesangial cells with IgA and IgA-containing circulating immune complexes. Kidney Int 62: 465-475, 2002 (Pubitemid 34779757)
34. Moura IC, Centelles MN, Arcos-Fajardo M, Malheiros DM, Collawn JF, Cooper MD, Monteiro RC: Identification of the transferrin receptor as a novel immunoglobulin (Ig)A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy. J Exp Med 194: 417-425, 2001 (Pubitemid 32835038)
35. Moura IC, Arcos-Fajardo M, Sadaka C, Leroy V, Benhamou M, Novak J, Vrtovsnik F, Haddad E, Chintalacharuvu KR, Monteiro RC: Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathy. J Am Soc Nephrol 15: 622-634, 2004 (Pubitemid 38294792)
36. Moura IC, Arcos-Fajardo M, Gdoura A, Leroy V, Sadaka C, Mahlaoui N, Lepelletier Y, Vrtovsnik F, Haddad E, Benhamou M, Monteiro RC: Engagement of transferrin receptor by polymeric IgA1: Evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy. J Am Soc Nephrol 16: 2667-2676, 2005
37. Zhang W, Lachmann PJ: Glycosylation of IgA is required for optimal activation of the alternative complement pathway by immune complexes. Immunology 81: 137-141, 1994 (Pubitemid 24249846)
38. Fritsche LG, Lauer N, Hartmann A, Stippa S, Keilhauer CN, Oppermann M, Pandey MK, Kohl J, Zipfel PF, Weber BH, Skerka C: An imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD). Hum Mol Genet 19: 4694-4704, 2010
39. Waldherr R, Rambousek M, Duncker WD, Ritz E: Frequency of mesangial IgA deposits in non-selected autopsy series. Nephrol Dial Transplant 4: 943-946, 1989 (Pubitemid 20050397)
40. Varis J, Rantala I, Pasternack A, Oksa H, Jantti M, Paunu ES, Pirhonen R: Immunoglobulin and complement deposition in glomeruli of 756 subjects who had committed suicide or met with a violent death. J Clin Pathol 46: 607-610, 1993 (Pubitemid 23231812)
41. Suzuki K, Honda K, Tanabe K, Toma H, Nihei H, Yamaguchi Y: Incidence of latent mesangial IgA deposition in renal allograft donors in Japan. Kidney Int 63: 2286-2294, 2003 (Pubitemid 36605844)
42. Shimozato S, Hiki Y, Odani H, Takahashi K, Yamamoto K, Sugiyama S: Serum under-galactosylated IgA1 is increased in Japanese patients with IgA nephropathy. Nephrol Dial Transplant 23: 1931-1939, 2008 (Pubitemid 351768162)
43. Matousovic K, Novak J, Tomana M, Kulhavy R, Julian BA, Mestecky J: IgA1-containing immune complexes in the urine of IgA nephropathy patients. Nephrol Dial Transplant 21: 2478-2484, 2006 (Pubitemid 44644520)
44. Julian BA, Wittke S, Novak J, Good DM, Coon JJ, Kellmann M, Zürbig P, Schiffer E, Haubitz M, Moldoveanu Z, Calcatera SM, Wyatt RJ, Sykora J, Sladkova E, Hes O, Mischak H, McGuire BM: Electrophoretic methods for analysis of urinary polypeptides in IgA-associated renal diseases. Electrophoresis 28: 4469-4483, 2007 (Pubitemid 350259049)
45. Gomes MM, Suzuki H, Brooks MT, Tomana M, Moldoveanu Z, Mestecky J, Julian BA, Novak J, Herr AB: Recognition of galactose-deficient O-glycans in the hinge region of IgA1 by N-acetylgalactosamine-specific snail lectins: A comparative binding study. Biochemistry 49: 5671-5682, 2010
46. Moore JS, Kulhavy R, Tomana M, Moldoveanu Z, Suzuki H, Brown R, Hall S, Kilian M, Poulsen K, Mestecky J, Julian BA, Novak J: Reactivities of N-acetylgalactosamine-specific lectins with human IgA1 proteins. Mol Immunol 44: 2598-2604, 2007 (Pubitemid 46240321)
47. Boehm MK, Woof JM, Kerr MA, Perkins SJ: The Fab and Fc fragments of IgA1 exhibit a different arrangement from that in IgG: A study by X-ray and neutron solution scattering and homology modelling. J Mol Biol 286: 1421-1447, 1999 (Pubitemid 29121726)
48. Herr AB, Ballister ER, Bjorkman PJ: Insights into IgA-mediated immune responses from the crystal structures of human FcαRI and its complex with IgA1-Fc. Nature 423: 614-620, 2003 (Pubitemid 36713216)
49. Gomes MM, Wall SB, Takahashi K, Novak J, Renfrow MB, Herr AB: Analysis of IgA1 Nglycosylation and its contribution to FcαRI binding. Biochemistry 47: 11285-11299, 2008
50. Suzuki H, Moldoveanu Z, Hall S, Brown R, Vu HL, Novak L, Julian BA, Tomana M, Wyatt RJ, Edberg JE, Alarcón GS, Kimberly RP, Tomino Y, Mestecky J, Novak J: IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1. J Clin Invest 118: 629-639, 2008 (Pubitemid 351206552)
51. Ju T, Cummings RD: Protein glycosylation: Chaperone mutation in Tn syndrome. Nature 437: 1252, 2005 (Pubitemid 41568663)
52. Iwasaki H, Zhang Y, Tachibana K, Gotoh M, Kikuchi N, Kwon YD, Togayachi A, Kudo T, Kubota T, Narimatsu H: Initiation of O-glycan synthesis in IgA1 hinge region is determined by a single enzyme, UDP-N-acetyl-α-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase 2. J Biol Chem 278: 5613-5621, 2003 (Pubitemid 36800803)
53. Raska M, Moldoveanu Z, Suzuki H, Brown R, Kulhavy R, Hall S, Vu HL, Carlsson F, Lindahl G, Tomana M, Julian BA, Wyatt RJ, Mestecky J, Novak J: Identification and characterization of CMP-NeuAc:GalNAc- IgA1 α2,6-sialyltransferase in IgA1-producing cells. J Mol Biol 369: 69-78, 2007 (Pubitemid 46635435)
54. Ju T, Brewer K, D'Souza A, Cummings RD, Canfield WM: Cloning and expression of human core 1 β1,3-galactosyltransferase. J Biol Chem 277: 178-186, 2002 (Pubitemid 34952043)
55. Julian BA, Novak J: IgA nephropathy: An update. Current Opin Nephrol Hypertens 13: 171-179, 2004 (Pubitemid 38373139)
56. Mestecky J, Tomana M, Moldoveanu Z, Julian BA, Suzuki H, Matousovic K, Renfrow MB, Novak L, Wyatt RJ, Novak J: The role of aberrant glycosylation of IgA1 molecules in the pathogenesis of IgA nephropathy. Kidney Blood Pres Res 31: 29-37, 2008 (Pubitemid 351310031)